For investors looking to assemble a portfolio of lasting, high-performing businesses, the quality investing philosophy offers a useful framework. This method centers on finding companies with durable competitive strengths, reliable profitability, and sound financial condition, with the plan of owning them for many years. One applied way to find these companies is the "Caviar Cruise" stock screen, which uses a set of numerical filters to find firms with a record of strong growth, high returns on capital, and trustworthy earnings. This screen focuses on measures like continued revenue and EBIT growth, a high Return on Invested Capital (ROIC), reasonable debt compared to free cash flow, and a good history of turning accounting profits into actual cash.
A recent search using this process has pointed to QIAGEN N.V. (NYSE:QGEN) as a candidate for more review by investors focused on quality. The Dutch life sciences tools provider, which allows molecular insights from biological samples, seems to fit many of the strategy's main financial requirements.
Performance and Growth Metrics
The Caviar Cruise screen looks for companies that have shown not only growth, but profitable and efficient growth. The filters demand a minimum 5% compound annual growth rate (CAGR) for both revenue and EBIT over five years, with EBIT growth preferably higher than revenue growth, a signal of better operational efficiency and possible pricing strength.
QIAGEN's past performance matches these goals well:
- Revenue Growth (5Y CAGR): 7.1% – This is above the 5% minimum, showing a steady increase in the company's sales.
- EBIT Growth (5Y CAGR): 9.6% – Notably, QIAGEN's earnings before interest and taxes have increased at a meaningfully higher rate than its revenue. This difference implies the company is effectively scaling its operations and turning more of each sales dollar into operating profit.
Profitability and Capital Efficiency
Central to quality investing is the idea of capital efficiency: how effectively a company produces returns from the money put into the business. The Caviar Cruise screen uses a strict ROIC filter (leaving out cash, goodwill, and intangibles) set above 15% to find top-tier capital allocators.
QIAGEN performs very well in this aspect:
- ROIC (Excluding Cash, Goodwill & Intangibles): 40.0% – This number is very high, greatly exceeding the screen's 15% standard. It shows that QIAGEN's main business operations are very profitable and that management is investing capital into projects that produce significant value. A high and steady ROIC is frequently a sign of a lasting competitive edge.
Financial Health and Earnings Quality
Quality investors look for financially stable companies whose stated profits are supported by genuine cash flow. The screen checks this through two important ratios: Debt-to-Free Cash Flow (a gauge of financial risk) and Profit Quality (the change of net income to free cash flow).
QIAGEN shows a firm profile here:
- Debt / Free Cash Flow: 4.5 – This ratio is within the screen's accepted limit of below 5. It suggests that, using its present yearly free cash flow, QIAGEN could pay off all its debt in less than five years, pointing to a controlled and careful debt level.
- Profit Quality (5Y Average): 189.7% – This result is very good, far above the 75% filter. An average over 100% across five years indicates QIAGEN has reliably created more free cash flow than its stated net income. This can point to careful accounting, efficient management of working capital, or a business model that naturally produces cash, offering important financial room for dividends, share repurchases, or strategic investment.
Fundamental Analysis Overview
A wider look at QIAGEN's fundamental analysis report gives background for these screen outcomes. The company receives an overall score of 6 out of 10, with specific high points in Profitability (8/10) and Financial Health (7/10). The report confirms leading operating and profit margins that place it in the best group of its Life Sciences Tools & Services industry. While its valuation is seen as reasonable compared to both the industry and the wider market, the report observes that growth has been steady. However, the rising revenue growth forecasts and stable EPS outlook support the view of a consistent, well-run business, a main factor for the buy-and-hold quality investor.
A Starting Point for Further Research
The Caviar Cruise screen is made as a tool to spot companies that have the numerical signs of a quality business. QIAGEN N.V., with its good growth profile, very high return on invested capital, strong cash generation, and firm financial health, clearly meets this first numerical check. For investors using this method, it stands as a notable candidate for more detailed, non-numerical investigation.
You can review other companies that meet the Caviar Cruise quality screen by viewing the full screen results here.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, a recommendation, or an offer to buy or sell any security. Investing involves risk, including the potential loss of principal. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.